期刊文献+

LOX在乳腺癌中的表达及与MMP-2、MMP-9相关性的实验研究 被引量:2

Expression of LOX in breast cancer and its correlation with MMP-2 and MMP-9
下载PDF
导出
摘要 目的探讨赖氨酰氧化酶(LOX)在不同侵袭、转移潜能的乳腺癌细胞株的表达及LOX与MMP-2、MMP-9的关系。方法以RT-PCR检测LOX mRNA在乳腺癌细胞株MDA-MB-231、MCF-7的表达水平。40只裸鼠随机分为2组,每组裸鼠的乳腺脂肪垫内分别接种上述不同的细胞,建立人乳腺癌原位移植瘤模型。6周后测定肿瘤体积,SP免疫组织化学法检测移植瘤中LOX、MMP-2、MMP-9的表达情况,并对数据进行统计学处理。结果高侵袭、转移潜能的乳腺癌细胞株MDA-MB-231中LOXmRNA表达量显著高于低侵袭、转移潜能的乳腺癌细胞株MCF-7(P<0.01);裸鼠接种癌细胞后第6天均有肿瘤形成,至6周时MDA-MB-231组肿瘤体积为(758.84±241.08)mm3,MCF-7组为(210.36±101.06)mm3,差异有统计学意义(P<0.01)。LOX与MMP-2、MMP-9的表达呈正相关(P<0.01)。结论乳腺癌细胞高侵袭、转移的潜能可能与LOX、MMP-2、MMP-9的高表达及其相互之间协同作用相关。 Objective To explore the expression of lysyl oxidase(LOX)in breast cancer and its relation to MMP-2 and MMP-9.Methods The expression level of LOX mRNA was detected by RT-PCR in breast cancer cell lines MDA-MB-231 and MCF-7 firstly.BALB/c nude mice were randomly divided into two groups,20 mice in each group.MDA-MB-231 and MCF-7 cells were implanted into the mammary fat pad of mice in each group respectively.Tumor volume was estimated six weeks after cell inoculation.Immunohistochemical method S-P was used to detect the expressions of LOX,MMP-2 and MMP-9 in the transplanted tumors,and the data were analyzed statistically.Results The highly invasive/metastatic breast cancer cell line MDA-MB-231 had much higher expression level of LOX mRNA than that of MCF-7(P0.01).Tumor occurred six days after cell inoculation.At the 6th week after inoculation,the tumor average size in group MDA-MB-231 and group MCF-7 were(758.84±241.08)mm3 and(210.36±101.06)mm3 respectively,and the difference between the two groups was statistically significant(P0.01).LOX was positively correlated with MMP-2 and MMP-9(P0.01).Conclusions The highly invasive/metastatic potential of breast cancer may be related to the high expression levels of LOX,MMP-2 and MMP-9,and to their synergistic effect.
出处 《中国癌症防治杂志》 CAS 2010年第4期265-269,共5页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 广西科学研究与技术开发计划课题(项目编号:桂科攻0816004-14)
关键词 乳腺肿瘤 裸鼠 肿瘤移植 赖氨酰氧化酶 基质金属蛋白酶-2 基质金属蛋白酶-9 Breast cancer Nude mouse Lysyl oxidase(LOX) MMP-2 MMP-9
  • 相关文献

参考文献10

  • 1Erler JT,Bennewith KL,Nicolau M,et al.Lysyl oxidase is essential for hypoxia-induced metastasis[J].Nature,2006,27,440(7088):1222-1226.
  • 2Morton CL,Houghton PJ.Establishment of human tumor xenografts in immunodeficient mice[J].Nat Protoc,2007,2(2):247-250.
  • 3Li Z,Huang X,Li J,et al.Human breast carcinoma xenografts in nude mice[J].Chin Med J(Engl),2002,115(2):222-226.
  • 4Kaneda A,Wakazono K,Tsukamoto T,et al.Lysyl oxidase is a tumor suppresson gene inactivated by methylation and loss of heterozygosity in human gastric cancers[J].Cancer Res,2004,64:6410-6415.
  • 5Holtmeier C,Gorogh T,Beier U,et al.Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas[J].Anticancer Res,2003,23:2585-2591.
  • 6Erler JT,Giaccia AJ.Lysyl oxidase mediates hypoxic control of metastasis[J].Cancer Res,2006,66(21):10238-10241.
  • 7Tester AM,Waltham M,Oh SJ,et al.Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231human breast cancer cells in nude mice[J].Cancer Res,2004,64(2):652-658.
  • 8Balduyck M,Zerimech F,Gouyer V,et al.Specific expression of matrix metalloproteinases 1,3,9 and 13 associated with invasiveness of breast cancer cells in vitro[J].Clin Exp Metastasis,2000,18(2):171-178.
  • 9Zucker S,Lysik RM,Zarrabi MH,et al.M(r) 92,000 type Ⅳ collagenase is increased in plasma of patients with colon cancer and breast cancer[J].Cancer Res,1993,53:140-146.
  • 10范松青,魏启幼,李美容,梁青春,张利群.MMP-2、MMP-9、TIMP-1和TIMP-2在乳腺癌中的表达及临床意义[J].诊断病理学杂志,2003,10(2):99-101. 被引量:15

二级参考文献7

  • 1Nawrocki B, Polette M, Marchand Vet al . Exppression of matrix metallo-proteinase and their inhibitor in human bronchopnlmonary carcinomas:quantificative and morphdogital analyses, Int J Cancer, 1997,72: 556.
  • 2Heppner KJ, Matrisian LM, Jonsen RA et al .Expression of most matrix metalloproteinase family members in breast cancer represonts a tumor induced host response.Am J Pathol, 1996,149:273.
  • 3Yoshikawa T,Saitoh M,Tsuburaya A et al .Tissue inhibitor of matrix metalloprotease-1 in the plasma of patients with gastric carcinoma:a possible marker for serosal invasion and metastasis. Cancer, 1999,86:1929.
  • 4Luparello C, Avanzato G, Carella C et al .Tissue inhibitor of metalloprotease(TIMP-1 ) and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat, 1999,54:235.
  • 5Talvensaari MA, Paakko P, Hoyhtya M et al .Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma.Cancer, 1998,83 : 1153.
  • 6李莉,张声,林华,林建银.基质金属蛋白酶和组织金属蛋白酶抑制剂表达失衡与胃癌浸润转移的关系[J].癌症,2002,21(3):305-310. 被引量:57
  • 7王岩,刘晓霞,侯正文,柳春晖,马秀萍,陈丽萍,贾支红,方虹.基质金属蛋白酶及其抑制剂在乳腺癌转移、浸润中的作用[J].临床与实验病理学杂志,2002,18(3):273-275. 被引量:12

共引文献14

同被引文献24

  • 1Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J C1in,2011,61(2) :69-90.
  • 2Fong SF, Dietzsch E, Fong KS, et al. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and asociated with lass differentiated colon turners[J]. Genes Chromosomes Cancer, 2007,46(7) :644-655.
  • 3Woznick AR, Braddock AL, Dulai M, et al. Lysyl oxidase expression in bronchogenic carcinoma[J]. Am J Surg, 2005, 189(3):297-301.
  • 4Erler JT, Bennewith KL, Nicolau M, et al. Lysyl oxidase is essential for hypoxia-indueed metastasis [J]. Nature, 2006, 440(7088) : 1222-1226.
  • 5Sui G,Soohoo C, Affarel B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cell[J]. Proc Natl Aead Sci U S A, 2002, 99(8):5515-5520.
  • 6Holtmeier C, Gorogh T, Beier U, et al. Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas[J]. Anticancer Res, 2003,23(3B) :2585-2591.
  • 7Daniele A,Zito AF,Giannelli G, et al. Expression of metalloproteinases MMP-2 and MMP-9 insentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer[J]. Anticancer Res,2010,30(9) :3521-3527.
  • 8Elizabeth CF, Amato JG. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease[J]. Cancer Metastasis, 2010, 29(2):285-293.
  • 9Jing DC, Blidaru A, Condrea I, et al. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors[J]. J Cell Mol Med, 2006, 10(2) : 499-510.
  • 10Shah FD, Shukla SN, Shah PM. Clinical significance of matrixmetalloproteinase 2 and 9 in breast eancer[J]. Indian J Cancer, 2009,46(3) : 194-202.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部